A CRISPR Approach to Neurodegenerative Diseases
IND faculty Dr. Martin Kampmann outlines a new strategy to investigate neurodegenerative diseases in a Perspective in press at Trends in Molecular Medicine. He co-developed a research platform based on CRISPR technology that enables activation and repression of each gene in human cells. This platform paves the way for a systematic elucidation of cellular factors that control neurodegeneration. Such factors are potential therapeutic targets in neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease. Read more about research in the Kampmann lab.